The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 11, 2022

Filed:

Jul. 20, 2020
Applicant:

Intron Biotechnology, Inc., Gyeonggi-do, KR;

Inventors:

Kwang Yeol Lee, Gyeonggi-do, KR;

Min Sik Kim, Seoul, KR;

Taek Hoon Kim, Seoul, KR;

Ngoc Phan Vu, Hanoi, VN;

Assignee:

INTRON BIOTECHNOLOGY, INC., Gyeonggi-do, KR;

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 49/18 (2006.01); C01G 45/02 (2006.01); B05D 7/00 (2006.01);
U.S. Cl.
CPC ...
A61K 49/186 (2013.01); A61K 49/1818 (2013.01); A61K 49/1875 (2013.01); B05D 7/54 (2013.01); C01G 45/02 (2013.01); C01P 2002/72 (2013.01); C01P 2004/04 (2013.01); C01P 2004/38 (2013.01); C01P 2004/84 (2013.01); C01P 2004/90 (2013.01);
Abstract

The present invention relates to a magnetic resonance imaging (MRI) contrast agent, particularly a metal oxide nanoparticle-based T1-T2 dual-mode MRI contrast agent that can be used not only as a T1 MRI contrast agent but also as a T2 MRI contrast agent, and a method for producing the same. The metal oxide nanoparticle-based T1-T2 dual-mode MRI contrast agent can provide more accurate and detailed information associated with disease than single MRI contrast agent by the beneficial contrast effects in both T1 imaging with high tissue resolution and T2 imaging with high feasibility on detection of a lesion.


Find Patent Forward Citations

Loading…